Moviprep

Polyethylene glycol (macrogol) with electrolytes and ascorbic acid, the active ingredient in Moviprep, is an osmotic laxative presented as a powder for oral solution for oral use. It is employed to cleanse the bowel before diagnostic procedures such as colonoscopy and sigmoidoscopy, providing effective bowel preparation in adult patients undergoing these examinations.

GNH USA supplies Moviprep as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide while adhering to stringent quality and regulatory standards.

Moviprep, an osmotic laxative, is used for bowel cleansing in gastrointestinal endoscopic procedures. - Colonoscopy: provides thorough bowel cleansing to improve visualization during the procedure. - Sigmoidoscopy: clears the distal colon to facilitate accurate examination. - CT colonography: ensures a clear colon lumen for optimal imaging results.

Moviprep may cause a range of adverse reactions, most of which are related to its osmotic activity and electrolyte content.

Common Side Effects: - Nausea: mild to moderate feeling of queasiness. - Abdominal bloating: sensation of fullness or distension. - Abdominal pain or cramps: intermittent discomfort. - Vomiting: occasional expulsion of stomach contents. - Thirst: increased desire to drink fluids. - Mild electrolyte imbalance: transient changes in sodium or potassium levels.

Serious or Rare Side Effects: - Severe dehydration: marked fluid loss requiring medical attention. - Significant electrolyte disturbances: such as hyponatremia or hypokalemia. - Acute renal impairment: sudden decline in kidney function. - Allergic reactions: rash, itching, or swelling. - Colonic perforation: rare but life‑threatening injury to the bowel wall.

Before prescribing Moviprep, clinicians should consider several safety precautions to minimize risks. - Assess renal function: evaluate kidney performance, especially in patients with chronic kidney disease. - Monitor electrolytes: check serum sodium and potassium before and after preparation. - Use cautiously in heart failure: fluid shifts may exacerbate cardiac conditions. - Avoid in known bowel obstruction: risk of worsening blockage. - Adjust dose for severe dehydration: consider alternative regimens or rehydration. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Moviprep can interact with other medicines, influencing fluid and electrolyte balance.

Major Interactions (Avoid): - Loop diuretics: combined use may precipitate severe hypokalemia. - High‑dose oral sodium phosphate preparations: additive osmotic load can cause dangerous electrolyte shifts. - ACE inhibitors or ARBs: risk of acute kidney injury when used together.

Moderate Interactions (Monitor Closely): - Antacids containing sodium or potassium: may alter electrolyte composition of the solution. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): can affect renal perfusion and increase dehydration risk. - Oral rehydration solutions: concurrent use may lead to excessive electrolyte intake.